跳至主導覽
跳至搜尋
跳過主要內容
長庚大學學術能量集萃 首頁
說明與常見問題
English
中文
首頁
學者概覽
研究單位
研究產出
研究計畫-專案
獎項
活動
按專業知識、姓名或所屬機構搜尋
藥理學科
長庚大學
醫學院
網站
https://dop.cgu.edu.tw/
概覽
指紋
網絡
學者概覽
(3)
研究計畫-專案
(76)
研究產出
(357)
獎項
(2)
指紋
查看啟用 藥理學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Drug
64%
ABCG2
61%
Magnetic Nanoparticle
56%
Multiple Drug Resistance
53%
Apoptosis
44%
Rat
37%
Reactive Oxygen Metabolite
35%
Nanoparticle
34%
Neoplasm
31%
Antiinfective Agent
27%
Alteplase
25%
Melatonin
23%
P-Glycoprotein
20%
Adenosine Triphosphate
18%
Bradykinin
18%
Fibrinolytic Agent
18%
Anticarcinogen
14%
Protein
13%
Phosphatidylinositol 3 Kinase
13%
Glioblastoma
13%
Calcium Ion
12%
Protein Tyrosine Kinase Inhibitor
12%
Photosensitizer
11%
Cancer Chemotherapy
11%
Thrombosis
11%
Polo Like Kinase 1
11%
Tissue Plasminogen Activator
11%
Hypoxia
11%
Verteporfin
10%
Effusion
9%
Calcium
9%
Cell Proliferation
9%
Mitochondrial DNA
9%
Receptor
8%
Polyphenol Derivative
8%
Mammalian Target of Rapamycin
8%
Epidermal Growth Factor Receptor
8%
Epigallocatechin Gallate
8%
Glioma
8%
Superparamagnetic Iron Oxide Nanoparticle
8%
Irradiation
8%
Chitosan
8%
Cytosolic Phospholipase A2
8%
Phosphatidylinositol 3 Kinase Inhibitor
8%
Antioxidant
7%
Blood-Brain Barrier
7%
Drug Administration
7%
Cyclooxygenase 2
7%
Aptamer
7%
Blood Clotting Factor
7%
Blood Clotting Factor 13
7%
Large for Gestational Age
7%
Pregnancy Diabetes Mellitus
7%
Histone Deacetylase 6
7%
20 Hydroxyicosatetraenoic Acid
7%
Histone Deacetylase
7%
Plasminogen Activator
7%
PEGylation
7%
Gelatinase B
7%
Sphingosine 1 Phosphate
7%
Cell Cycle
6%
Adenosine Triphosphatase
6%
Photodynamic Therapy
6%
Nanocomposite
6%
Lysine
6%
Combination Therapy
6%
Nanocarrier
6%
Carboxymethyldextran
6%
Diseases
5%
Nuclear Factor
5%
Alternative Complement Pathway C3 C5 Convertase
5%
Non Small Cell Lung Cancer
5%
Mitogen Activated Protein Kinase 3
5%
Epidermal Growth Factor Receptor Kinase Inhibitor
5%
Natural Product
5%
Dextran
5%
Messenger RNA
5%
Gallic Acid
5%
Bioavailability
5%
Iron
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
79%
ABCG2
66%
Species
50%
Magnetism
48%
Astrocyte
37%
Apoptosis
35%
Melatonin
34%
Multidrug Resistance
34%
Rat
32%
ABC Transporter
23%
Oxidative Stress
23%
Mitochondrion
21%
Kinase
21%
Anticancer
18%
Mitochondrial Permeability
17%
Protein
16%
Stress
16%
Tissue Plasminogen Activator
15%
Mitogen-Activated Protein Kinase
15%
Cytoplasmic Hybrid
14%
Calcium
12%
Matrix Metalloproteinase
11%
Drug Resistance
11%
Epidermal Growth Factor Receptor
11%
Induced Mutation
11%
Mitochondrial DNA
11%
Development
11%
Phosphatidylinositol
11%
Histone Deacetylase
11%
Pregnancy
11%
Internalization
11%
Time
10%
Tyrosine Kinase Inhibitor
10%
Cardiolipin
10%
Iron
10%
Phenotype
9%
P-Glycoprotein
9%
Interleukin-1
9%
Blood Clot Lysis
8%
Phospholipase A2
8%
Mitochondrial Permeability Transition Pore
8%
Tumor Hypoxia
7%
Age
7%
Phosphorylation
7%
Metabolite
7%
Mouse
7%
NAD(P)H Oxidase
7%
Magnetic Resonance Imaging
7%
ATP Synthase
7%
Blood Brain Barrier
7%
Ultrasound
7%
Vemurafenib
7%
Mutation
6%
Surface Property
6%
Force
6%
Electron Transport Chain
6%
Peptide
5%
Receptor Tyrosine Kinase Inhibitors
5%
Mutant
5%
Mediator
5%
Staining
5%
Solid
5%
N-Terminus
5%
Dextran
5%
Epigallocatechin Gallate
5%
ATPase
5%
Drug Transport
5%
Medicine and Dentistry
Cells
31%
Cancer Cell
26%
Breast Cancer Resistance Protein
23%
Chemotherapeutic Agent
22%
Drug
22%
Combination Therapy
22%
Magnetic Nanoparticle
22%
ABC Transporter
21%
Astrocyte
18%
Multidrug Resistance
15%
Reactive Oxygen Species
15%
Gelatinase B
12%
Evaluation Study
11%
Programmed Cell Death
11%
Pregnancy
11%
Brain
11%
Placenta
10%
Therapeutic Procedure
9%
ABC Transporter Subfamily B
9%
Nanoparticle
8%
In Vitro
8%
Adenosine Triphosphate
8%
Vascular Smooth Muscle Cell
8%
Internalization
8%
Drug Resistance
8%
Mechanistic Target of Rapamycin
8%
Medicine
7%
Drug Administration
7%
Glioblastoma
7%
Large for Gestational Age
7%
Gestational Diabetes
7%
Fibrinolytic Therapy
7%
Optical Coherence Tomography
7%
Mitochondrion
7%
Mitogen-Activated Protein Kinase
7%
Vemurafenib
7%
Phosphoinositide 3-Kinase Inhibitor
7%
Woman
7%
Tissues
7%
Phosphoinositide 3-Kinase
6%
Malignant Neoplasm
6%
Metastatic Carcinoma
6%
Development
6%
Neoplasm
5%
Infant
5%
Nuclear Factor
5%
Alternative Complement Pathway C3 C5 Convertase
5%
Mitochondrial ROS
5%
Multidrug Resistance Protein 1
5%
Tumor Necrosis Factor
5%
Cancer Cell Line
5%